You have 9 free searches left this month | for more free features.

Condition

Colorectal Cancer (1)

Gastric Cancer (1)

Hepatocellular Carcinoma (1)

Metastasis (1)

Oesophageal Squamous Cell Carcinoma (1)

Oseophageal Adenocarcinoma (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Sanofi (1)

Synthorx, Inc, a Sanofi company (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

thor-707 (2)

anti-egfr antibody (1)

cetuximab (1)

checkpoint inhibitor (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

thor-707

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastasis Trial in Australia, Singapore, United States (THOR-707, Checkpoint inhibitor, anti-EGFR antibody)

Recruiting

Metastasis

THOR-707
+2 more

Scottsdale, Arizona
+12 more

Feb 10, 2022

Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

Active, not recruiting

Oesophageal Squamous Cell Carcinoma
+4 more

THOR-707
+2 more

Duarte, California
+39 more

Oct 31, 2022